BeOne Medicines
ONC
#755
Rank
C$44.36 B
Marketcap
C$399.24
Share price
-0.48%
Change (1 day)
12.99%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): C$0.65 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are C$5.34 Billion. , an increase over its 2024 earnings that were of -C$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 C$0.64 B-183.61%
2024 -C$0.78 Billion-52.95%
2023 -C$1.65 Billion-32.52%
2022 -C$2.44 Billion24.39%
2021 -C$1.96 Billion-13.21%
2020 -C$2.26 Billion72.69%
2019 -C$1.31 Billion36.01%
2018 -C$0.96 Billion616.83%
2017 -C$0.14 Billion-15.24%
2016 -C$0.16 Billion107.91%
2015 -C$75.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.22 Billion-133.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$24.67 Million-103.82%๐Ÿ‡บ๐Ÿ‡ธ USA